综述:上消化道出血——当前证据回顾及对管理的启示
本综述通过结构化文献检索,系统更新了急性上消化道出血在内镜前、内镜中和内镜后各阶段的管理证据。内镜前管理包括风险分层、限制性红细胞输注策略(除非患者有心血管疾病)、红霉素和质子泵抑制剂药物治疗;肝硬化患者应使用预防性抗生素和血管活性药物,不应使用氨甲环酸。内镜管理取决于病因,消化性溃疡高风险征象应行内镜治疗,静脉曲张出血按严重程度和解剖位置个体化治疗。
要点
- 急性上消化道出血内镜前管理包括风险分层、限制性输血(心血管疾病患者除外)、红霉素和质子泵抑制剂。
- 肝硬化患者应使用预防性抗生素和血管活性药物,不应使用氨甲环酸。
- 消化性溃疡高风险征象应行内镜治疗;静脉曲张出血按严重程度和解剖位置个体化治疗。
核心结论
- 急性上消化道出血的管理应包括内镜前、内镜中和内镜后各阶段的治疗计划,并根据病因和出血严重程度个体化治疗决策。
研究设计与样本
- 综述:针对每个主题进行结构化文献数据库检索;若无近期高质量Meta分析,则采用随机效应方法进行Meta分析,计算比值比及95%置信区间。
主要发现
- 内镜前管理包括风险分层、限制性红细胞输注策略(除非患者有心血管疾病)、红霉素和质子泵抑制剂药物治疗。
- 肝硬化患者应使用预防性抗生素和血管活性药物;不应使用氨甲环酸。
- 消化性溃疡伴高风险征象应行内镜治疗,包括超镜夹(OTSCs)和TC-325粉末喷洒。
- 静脉曲张出血治疗应根据严重程度和解剖位置个体化。
- 内镜后管理包括所有上消化道出血患者早期肠内喂养;高风险消化性溃疡质子泵抑制剂应持续72小时,再出血应首先用重复内镜评估;静脉曲张出血高风险或再出血患者可考虑经颈静脉肝内门体分流术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute upper gastrointestinal bleeding (UGIB) is a common emergency requiring hospital-based care. Advances in care across pre-endoscopic, endoscopic and post-endoscopic phases have led to improvements in clinical outcomes. AIMS: To provide a detailed, evidence-based update on major aspects of care across pre-endoscopic, endoscopic and post-endoscopic phases. METHODS: We performed a structured bibliographic database search for each topic. If a recent high-quality meta-analysis was not available, we performed a meta-analysis with random effects methods and odds ratios with 95% confidence intervals. RESULTS: Pre-endoscopic management of UGIB includes risk stratification, a restrictive red blood cell transfusion policy unless the patient has cardiovascular disease, and pharmacologic therapy with erythromycin and a proton pump inhibitor. Patients with cirrhosis should be treated with prophylactic antibiotics and vasoactive medications. Tranexamic acid should not be used. Endoscopic management of UGIB depends on the aetiology. For peptic ulcer disease (PUD) with high-risk stigmata, endoscopic therapy, including over-the-scope clips (OTSCs) and TC-325 powder spray, should be performed. For variceal bleeding, treatment should be customised by severity and anatomic location. Post-endoscopic management includes early enteral feeding for all UGIB patients. For high-risk PUD, PPI should be continued for 72 h, and rebleeding should initially be evaluated with a repeat endoscopy. For variceal bleeding, high-risk patients or those with further bleeding, a transjugular intrahepatic portosystemic shunt can be considered. CONCLUSIONS: Management of acute UGIB should include treatment plans for pre-endoscopic, endoscopic and post-endoscopic phases of care, and customise treatment decisions based on aetiology and severity of bleeding.
引用
- Shung DL, Laine L. Review article: Upper gastrointestinal bleeding - review of current evidence and implications for management. Aliment Pharmacol Ther. 2024. PMID: 38517201. doi:10.1111/apt.17949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。